Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.464NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.234NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.231NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.243NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.517NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.291NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.349NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.314NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.132NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.256NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.77NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.248NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.43NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.559NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.406NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.69NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ER.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.640NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.9 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XUNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.3 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.16.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.372NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.425NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AD.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.26.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.10.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBTNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used